U.S. to Buy Lilly Antibody; Germany’s New Curbs: Virus Update
5 years ago 1 min read
The U.S. agreed to pay Eli Lilly & Co. $375 million for 300,000 vials of its experimental Covid-19 antibody, underscoring governments’ appetite for any pandemic solution as the virus stages a comeback in the northern hemisphere.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push